Total Payments
$7,406
2024 Payments
$98.79
Companies
31
Transactions
248
Medicare Patients
10,604
Medicare Billing
$797,406
Payment Breakdown by Category
Food & Beverage$5,354 (72.3%)
Travel$1,956 (26.4%)
Education$79.99 (1.1%)
Other$15.25 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,354 | 242 | 72.3% |
| Travel and Lodging | $1,956 | 3 | 26.4% |
| Education | $79.99 | 2 | 1.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15.25 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BIOTRONIK INC. | $2,127 | 4 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $1,305 | 77 | $0 (2023) |
| Boston Scientific Corporation | $631.66 | 21 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $491.10 | 17 | $0 (2024) |
| Abbott Laboratories | $425.65 | 6 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $315.90 | 13 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $311.07 | 22 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $257.92 | 8 | $0 (2023) |
| Esperion Therapeutics, Inc. | $163.54 | 10 | $0 (2022) |
| Penumbra, Inc. | $140.06 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $98.79 | 4 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($79.09) |
| 2023 | $445.66 | 15 | Abbott Laboratories ($147.80) |
| 2022 | $640.31 | 35 | Novartis Pharmaceuticals Corporation ($158.42) |
| 2021 | $1,020 | 49 | Novartis Pharmaceuticals Corporation ($459.40) |
| 2020 | $285.74 | 18 | Novartis Pharmaceuticals Corporation ($127.32) |
| 2019 | $2,516 | 25 | BIOTRONIK INC. ($2,127) |
| 2018 | $1,137 | 47 | Boston Scientific Corporation ($212.35) |
| 2017 | $1,263 | 55 | Novartis Pharmaceuticals Corporation ($345.65) |
All Payment Transactions
248 individual payment records from CMS Open Payments — Page 2 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/16/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/09/2022 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 09/01/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/09/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/27/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/20/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Cardiology | ||||||
| 06/09/2022 | Kiniksa Pharmaceuticals, Ltd. | Arcalyst (Drug) | Food and Beverage | Cash or cash equivalent | $16.84 | General |
| Category: Rheumatology | ||||||
| 06/02/2022 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/02/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/20/2022 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/12/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/11/2022 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 05/10/2022 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/26/2022 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/26/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $5.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/18/2022 | Impulse Dynamics (USA) Inc. | Optimizer (Device) | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: Cardiovascular | ||||||
| 03/14/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Cardiovascular | ||||||
| 03/09/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/08/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Cardiology | ||||||
| 03/03/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: DIABETES | ||||||
| 02/28/2022 | Kiniksa Pharmaceuticals, Ltd. | Arcalyst (Drug) | Food and Beverage | Cash or cash equivalent | $20.56 | General |
| Category: Rheumatology | ||||||
| 02/17/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/08/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Diabetes | ||||||
| 02/02/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.36 | General |
| Category: Cardiovascular | ||||||
| 02/01/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 2,346 | 2,973 | $711,960 | $149,344 |
| 2022 | 28 | 3,437 | 4,444 | $1.0M | $244,812 |
| 2021 | 27 | 2,540 | 3,497 | $955,035 | $240,368 |
| 2020 | 27 | 2,281 | 2,942 | $650,853 | $162,883 |
Total Patients
10,604
Total Services
13,856
Medicare Billing
$797,406
Procedure Codes
130
All Medicare Procedures & Services
130 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 253 | 254 | $122,401 | $23,985 | 19.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 208 | 249 | $89,041 | $21,538 | 24.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 101 | 119 | $60,672 | $15,187 | 25.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 101 | 211 | $56,246 | $13,941 | 24.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 246 | 249 | $75,070 | $13,540 | 18.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 64 | 95 | $33,329 | $9,384 | 28.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 53 | 56 | $35,374 | $7,979 | 22.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 65 | 68 | $31,725 | $7,416 | 23.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 24 | 96 | $19,455 | $4,629 | 23.8% |
| 93798 | Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | Office | 2023 | 43 | 208 | $21,068 | $4,073 | 19.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 394 | 511 | $44,438 | $3,409 | 7.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $12,559 | $3,078 | 24.5% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 95 | 95 | $14,621 | $3,073 | 21.0% |
| Q9957 | Injection, perflutren lipid microspheres, per ml | Office | 2023 | 40 | 80 | $11,021 | $2,917 | 26.5% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 27 | 29 | $11,826 | $2,446 | 20.7% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 12 | 12 | $11,369 | $2,431 | 21.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 24 | 26 | $9,748 | $2,083 | 21.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 29 | 29 | $8,097 | $1,644 | 20.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 250 | 262 | $8,157 | $1,178 | 14.4% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2023 | 18 | 18 | $5,592 | $967.38 | 17.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 14 | 14 | $4,156 | $942.14 | 22.7% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 17 | 17 | $3,722 | $775.48 | 20.8% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 25 | 26 | $2,665 | $529.03 | 19.8% |
| 93319 | 3d ultrasound imaging of heart for evaluation of heart structure performed during ultrasound imaging of congenital heart defects | Facility | 2023 | 17 | 18 | $4,334 | $344.62 | 8.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 25 | 25 | $1,363 | $279.13 | 20.5% |
About Dr. Sandeep Mehta, M.D
Dr. Sandeep Mehta, M.D is a Cardiovascular Disease healthcare provider based in Maywood, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2012. The National Provider Identifier (NPI) number assigned to this provider is 1780939967.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sandeep Mehta, M.D has received a total of $7,406 in payments from pharmaceutical and medical device companies, with $98.79 received in 2024. These payments were reported across 248 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($5,354).
As a Medicare-enrolled provider, Mehta has provided services to 10,604 Medicare beneficiaries, totaling 13,856 services with total Medicare billing of $797,406. Data is available for 4 years (2020–2023), covering 130 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease, Internal Medicine
- Location Maywood, IL
- Active Since 07/13/2012
- Last Updated 07/28/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1780939967
Products in Payments
- ENTRESTO (Drug) $1,125
- LifeVest (Device) $491.10
- XARELTO (Drug) $311.07
- WATCHMAN (Device) $253.73
- BRILINTA (Drug) $186.55
- PRALUENT (Biological) $174.97
- NEXLETOL (Drug) $163.54
- LEQVIO (Drug) $158.42
- Perclose ProGlide suture mediated closure system (Device) $153.53
- MITRACLIP (Device) $147.80
- EVKEEZA (Biological) $140.93
- Indigo System (Device) $140.06
- SAMSCA (Drug) $127.91
- Repatha (Biological) $127.90
- ELIQUIS (Drug) $110.22
- Vascepa (Drug) $89.84
- Arcalyst (Drug) $71.39
- Mitra Clip system (Device) $68.50
- RESONATE (Device) $67.74
- PRADAXA (Drug) $67.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Maywood
Erin Coglianese, M.d, M.D
Cardiovascular Disease — Payments: $37,383
Cardiovascular Disease $37,383
Dr. Sukit Ringwala, M.d, M.D
Cardiovascular Disease — Payments: $30,360
Cardiovascular Disease $30,360
Dr. Demetrios Doukas, D.o, D.O
Cardiovascular Disease — Payments: $26,618
Cardiovascular Disease $26,618
Dr. Kenneth Brownell, M.d, M.D
Cardiovascular Disease — Payments: $20,568
Cardiovascular Disease $20,568
Amir Darki, M.d, M.D
Cardiovascular Disease — Payments: $17,823
Cardiovascular Disease $17,823
Subir Shah, D.o, D.O
Cardiovascular Disease — Payments: $7,194
Cardiovascular Disease $7,194